23.68 - 23.68
20.75 - 25.07
1.4K / 5.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.94%
Negative revenue growth while Insurance - Life median is 0.12%. Seth Klarman would investigate if the company is losing market share or facing a declining industry.
-2.94%
Negative gross profit growth while Insurance - Life median is 0.00%. Seth Klarman would suspect poor product pricing or inefficient production.
-1.15%
Negative EBIT growth while Insurance - Life median is -0.57%. Seth Klarman would check if external or internal factors caused the decline.
-1.15%
Negative operating income growth while Insurance - Life median is -1.15%. Seth Klarman would check if structural or cyclical issues are at play.
-0.34%
Negative net income growth while Insurance - Life median is 0.00%. Seth Klarman would investigate factors dragging net income down.
-0.34%
Negative EPS growth while Insurance - Life median is 0.83%. Seth Klarman would explore whether share dilution or profit declines are to blame.
-0.35%
Negative diluted EPS growth while Insurance - Life median is 0.85%. Seth Klarman would look for the cause: weakened profitability or heavier share issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
29.97%
OCF growth near Insurance - Life median of 28.80%. Charlie Munger might attribute it to typical sector or cyclical patterns.
111.87%
FCF growth exceeding 1.5x Insurance - Life median of 38.35%. Joel Greenblatt would see if high profitability or prudent capex drives outperformance.
130.20%
10Y revenue/share CAGR 1.25-1.5x Insurance - Life median of 117.30%. Mohnish Pabrai would see if consistent reinvestment or product expansions drive this gap.
94.80%
5Y revenue/share growth exceeding 1.5x Insurance - Life median of 42.70%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.
90.77%
3Y revenue/share growth exceeding 1.5x Insurance - Life median of 24.21%. Joel Greenblatt might see a short-term competitive advantage at play.
No Data
No Data available this quarter, please select a different quarter.
182.49%
5Y OCF/share growth exceeding 1.5x Insurance - Life median of 82.66%. Joel Greenblatt might see a strong moat or efficient cost structure driving outperformance.
155.99%
3Y OCF/share growth > 1.5x Insurance - Life median of 17.70%. Joel Greenblatt might see a recent competitive advantage translating into cash improvements.
370.17%
Net income/share CAGR exceeding 1.5x Insurance - Life median of 206.51% over a decade. Joel Greenblatt might see a standout compounder of earnings.
205.69%
5Y net income/share CAGR > 1.5x Insurance - Life median of 98.45%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
143.54%
3Y net income/share CAGR > 1.5x Insurance - Life median of 49.52%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
No Data
No Data available this quarter, please select a different quarter.
206.65%
5Y equity/share CAGR > 1.5x Insurance - Life median of 39.53%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
143.14%
3Y equity/share CAGR > 1.5x Insurance - Life median of 5.48%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-3.10%
Assets shrink while Insurance - Life median grows. Seth Klarman might see a strategic refocus or potential missed expansion if demand is present.
-3.83%
Negative BV/share change while Insurance - Life median is 0.00%. Seth Klarman sees a firm-specific weakness if peers accumulate net worth.
105.61%
Debt growth far outpacing Insurance - Life median. Jim Chanos suspects over-leveraging or deteriorating financial discipline.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.